Studies with IKKβ, TRAF2 and PERK knockout sub-lines of 786-O cells demonstrated that activation of both NF-κB and PERK was essential for sunitinib-induced production of IL-6 and IL-8 in tumor cells (Fig. 4b). The gene discussed is IL6; the disease is neoplasm.